Condition: Pulmonary Embolism Acute · Sponsor: Angiodynamics, Inc.
The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.
This description comes directly from the study's public registry record.
Elizabeth Manning · 339-237-2765 · liz.manning@angiodynamics.com
Always discuss trial participation with your own doctor first.
| CentraCare Heart and Vascular Center | Saint Cloud, Minnesota, United States | Recruiting |
| University at Buffalo | Buffalo, New York, United States | Recruiting |
| Jacobi Medical Center | The Bronx, New York, United States | Recruiting |
| Kettering Health | Kettering, Ohio, United States | Recruiting |
| Baylor Heart Hospital Plano | Plano, Texas, United States | Recruiting |
| Methodist Healthcare | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07280247